NUWELLIS, INC. Amortization of Debt Issuance Costs
NUWELLIS, INC. (NUWE) reported Amortization of Debt Issuance Costs of $6.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-13
- NUWELLIS, INC. amortization of debt issuance costs for the quarter ending 2026-06-30 was $6.08M, a 42.41% decline year-over-year.
- NUWELLIS, INC. amortization of debt issuance costs for the quarter ending 2025-12-31 was $0.00.
- NUWELLIS, INC. amortization of debt issuance costs for the quarter ending 2025-09-30 was $0.00.
- NUWELLIS, INC. amortization of debt issuance costs for the quarter ending 2025-06-30 was $10.55M, a 88.21% increase year-over-year.
- NUWELLIS, INC. amortization of debt issuance costs for fiscal 2025 was $10.55M, a 88.21% increase from fiscal 2024.
- NUWELLIS, INC. amortization of debt issuance costs for fiscal 2024 was $5.61M, a 60.98% increase from fiscal 2023.
- NUWELLIS, INC. amortization of debt issuance costs for fiscal 2023 was $3.48M, a 62.33% decline from fiscal 2022.
- NUWELLIS, INC. amortization of debt issuance costs for fiscal 2022 was $9.25M.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.08M 10-Q · filed 2026-08-13 | $6.08M 10-Q · filed 2026-08-13 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $10.55M derived: sum of 3 quarters · filed 2026-08-13 | $10.55M 10-K · filed 2026-03-11 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $10.55M derived: sum of 2 quarters · filed 2026-08-13 | $10.55M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $10.55M 10-Q · filed 2026-08-13 | $10.55M 10-Q · filed 2026-08-13 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 derived: sum of 2 quarters · filed 2026-03-11 | $5.61M derived: sum of 3 quarters · filed 2026-03-11 | $5.61M 10-K · filed 2026-03-11 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $5.61M derived: sum of 2 quarters · filed 2025-11-12 | $5.61M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $5.61M 10-Q · filed 2025-08-14 | $5.61M 10-Q · filed 2025-08-14 | ||
| 2023-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $3.48M derived: sum of 2 quarters · filed 2025-03-11 | $3.48M derived: sum of 3 quarters · filed 2025-03-11 | $3.48M 10-K · filed 2025-03-11 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | ||
| 2022-12-31 | $9.25M 10-K · filed 2024-03-11 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |